Inspire Medical Systems Outperforms Alternate Health in Key Metrics

Inspire Medical's strong institutional backing and profitability make it the preferred investment over Alternate Health.

Apr. 13, 2026 at 4:08am

An extreme close-up of sleek, metallic medical equipment and machinery, conveying the advanced, industrial nature of Inspire Medical Systems' sleep apnea treatments.Inspire Medical Systems' innovative sleep apnea technology showcases the company's engineering prowess and institutional backing.Golden Valley Today

Inspire Medical Systems (NYSE:INSP) and Alternate Health (OTCMKTS:AHGIF) are both medical companies, but Inspire Medical Systems is the stronger investment based on a comparison of the two companies' institutional ownership, profitability, analyst recommendations, and other key metrics.

Why it matters

This analysis provides investors with a data-driven comparison of two medical technology companies, helping them make more informed decisions about where to allocate their capital.

The details

Inspire Medical Systems has significantly stronger institutional ownership at 94.9% compared to Alternate Health's unknown institutional backing. Inspire Medical also has higher profitability metrics like net margins, return on equity, and return on assets. Analysts are more bullish on Inspire Medical, giving it a higher consensus target price and stronger buy ratings.

  • The analysis was published on April 13, 2026.

The players

Inspire Medical Systems, Inc.

A medical technology company focused on developing minimally invasive solutions for patients with obstructive sleep apnea, headquartered in Golden Valley, Minnesota.

Alternate Health Corp.

A diversified healthcare company providing cloud-based software solutions, lab services, and other products to the medical cannabis industry, headquartered in Toronto, Canada.

Got photos? Submit your photos here. ›

The takeaway

This analysis highlights Inspire Medical Systems' clear advantages over Alternate Health in terms of institutional backing, profitability, and analyst sentiment, making it the more attractive investment option for those looking to gain exposure to the medical technology sector.